Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Operations (2020 - 2025)

PROCEPT BioRobotics has reported Cash from Operations over the past 6 years, most recently at 10327000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 10327000.0 for Q4 2025, up 68.12% from a year ago — trailing twelve months through Dec 2025 was 48985000.0 (up 50.63% YoY), and the annual figure for FY2025 was 48985000.0, up 50.63%.
  • Cash from Operations for Q4 2025 was 10327000.0 at PROCEPT BioRobotics, down from 6635000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PRCT hit a ceiling of 6635000.0 in Q3 2025 and a floor of 35928000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 17678500.0 (2022), compared with a mean of 19695850.0.
  • Biggest five-year swings in Cash from Operations: plummeted 97.07% in 2023 and later soared 68.12% in 2025.
  • PROCEPT BioRobotics' Cash from Operations stood at 16476000.0 in 2021, then tumbled by 52.79% to 25174000.0 in 2022, then grew by 1.51% to 24793000.0 in 2023, then crashed by 30.65% to 32391000.0 in 2024, then soared by 68.12% to 10327000.0 in 2025.
  • The last three reported values for Cash from Operations were 10327000.0 (Q4 2025), 6635000.0 (Q3 2025), and 15043000.0 (Q2 2025) per Business Quant data.